Protalix BioTherapeutics
- Biological Products, Except Diagnostic Substances
- Hackensack, New Jersey
Compensation history
Top executives at Protalix BioTherapeutics received an average of $804K per person in annual compensation from 2006 to 2023.
Average pay of disclosed executives at Protalix BioTherapeutics
By year
Executives
We found 11 executives who work or worked at Protalix BioTherapeutics.
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
Eyal Rubin
Protalix BioTherapeutics
Chief Financial Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Chief Development Officer
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020
Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
April 12, 2019
About Protalix BioTherapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address2 University Plaza, Suite 100, Hackensack, New Jersey 07601
- Phone201-696-9345
- Fiscal year endDecember 31
- Former names
- ORTHODONTIX INCUntil February 21, 2007
- EMBASSY ACQUISITION CORPUntil March 30, 1998
Source: SEC filings on April 29, 2024, May 18, 2023, April 29, 2022, April 15, 2020, April 12, 2019, March 6, 2018, March 16, 2017, October 9, 2014, September 19, 2013, May 21, 2012, September 19, 2011, September 17, 2009, and October 3, 2008.